EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease

Georgios N. Dimitrakopoulos, Aristidis G. Vrahatis, Themis P. Exarchos, Marios G. Krokidis, Panagiotis Vlamos

Future Pharmacology · 12.10.2023 · 3 (4) · 731-741

DOI: 10.3390/futurepharmacol3040045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 12.10.2023. Verfasst von Georgios N. Dimitrakopoulos und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease is one of the leading causes of death globally, significantly impacting countless families and communities. In parallel, recent advancements in molecular biology and network approaches, guided by the Network Medicine perspective, offer promising outcomes for Alzheimer’s disease research and treatment. In this study, we aim to discover candidate therapies for AD through drug repurposing. We combined a protein-protein interaction (PPI) network with drug-target interactions. Experimentally validated PPI data were collected from the PICKLE meta-database, while drugs and their protein targets were sourced from the DrugBank database. Then, based on RNA-Seq data, we first assigned weights to edges to indicate co-expression, and secondly, estimated differential gene expression to select a subset of genes potentially related to the disease. Finally, small subgraphs (modules) were extracted from the graph, centered on the genes of interest. The analysis revealed that even if there is no drug targeting several genes of interest directly, an existing drug might target a neighboring node, thus indirectly affecting the aforementioned genes. Our approach offers a promising method for treating various diseases by repurposing existing drugs, thereby reducing the cost and time of experimental procedures and paving the way for more precise Network Medicine strategies.

Förderung

  • European Union

Zitieren

APA

Dimitrakopoulos, G. N., Vrahatis, A. G., Exarchos, T. P., Krokidis, M. G., & Vlamos, P. (2023). Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease. Future Pharmacology, 3(4), 731-741. https://doi.org/10.3390/futurepharmacol3040045

Vancouver

Dimitrakopoulos GN, Vrahatis AG, Exarchos TP, Krokidis MG, Vlamos P. Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease. Future Pharmacology. 2023;3(4):731-741. doi:10.3390/futurepharmacol3040045

BibTeX
@article{Dimitrakopoulos2023,
  author = {Dimitrakopoulos, Georgios N. and Vrahatis, Aristidis G. and Exarchos, Themis P. and Krokidis, Marios G. and Vlamos, Panagiotis},
  title = {Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease},
  journal = {Future Pharmacology},
  year = {2023},
  volume = {3},
  number = {4},
  pages = {731--741},
  doi = {10.3390/futurepharmacol3040045}
}
Kostenlos starten →